Morphological analysis of mitochondria for evaluating the toxicity of α-synuclein in transgenic mice and isolated

Ge Gao1, Zhipeng Wang1, Lingling Lu1

  • 1Department of Neurobiology, Capital Medical University, Center of Parkinson Disease Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing, 100069, China.

Insights

Alpha-synuclein (α-syn) causes mitochondrial damage in Parkinson's disease. This study reveals α-syn directly alters mitochondrial morphology and function by affecting the mitochondrial permeability transition pore (mPTP) and cardiolipin levels.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial damage is a key factor in Parkinson's disease pathogenesis.
  • Alpha-synuclein (α-syn) is implicated in this damage, but the mechanism altering mitochondrial morphology is unclear.

Purpose of the Study:

  • Investigate how α-syn affects mitochondrial morphology and function.
  • Examine the role of mitochondrial permeability transition pore (mPTP) opening and cardiolipin (CL) levels in α-syn-induced mitochondrial dysfunction.

Main Methods:

  • Isolated mitochondria from Thy1-α-syn transgenic mice.
  • Atomic force microscopy (AFM) for morphological analysis.
  • Biochemical assays for cytochrome C, caspase-3, CL levels, mitochondrial membrane potential, and complex I activity.
  • Treatment with mPTP inhibitor cyclosporin A.

Main Results:

  • Transgenic mice showed increased cytoplasmic cytochrome C and cleaved caspase-3.
  • AFM revealed correlations between mitochondrial morphology and function.
  • Recombinant α-syn N-terminus (α-syn/N) reduced CL content, induced mitochondrial swelling, and pore formation.
  • α-syn/N decreased mitochondrial membrane potential and complex I activity.
  • Cyclosporin A abrogated dysfunction but not CL reduction.

Conclusions:

  • α-syn/N directly impairs mitochondrial structure and function by modulating mPTP opening and CL levels.
  • AFM is a valuable tool for assessing mitochondrial injury in neurodegenerative diseases.

Related Concept Videos